tiprankstipranks
Magenta Therapeutics adopts stockholder rights plan
PremiumThe FlyMagenta Therapeutics adopts stockholder rights plan
1y ago
Magenta Therapeutics initiated with a Neutral at H.C. Wainwright
PremiumThe Fly
Magenta Therapeutics initiated with a Neutral at H.C. Wainwright
1y ago
Magenta Therapeutics downgraded to Neutral at BTIG after MGTA-117 trial paused
PremiumThe Fly
Magenta Therapeutics downgraded to Neutral at BTIG after MGTA-117 trial paused
1y ago
Magenta Therapeutics Voluntarily Pauses the MGTA-117 Phase 1/2 Dose-Escalation Clinical Trial to Investigate Drug Safety
PremiumPress ReleasesMagenta Therapeutics Voluntarily Pauses the MGTA-117 Phase 1/2 Dose-Escalation Clinical Trial to Investigate Drug Safety
1y ago
Magenta Therapeutics price target lowered to $3 from $6 at BTIG
PremiumThe Fly
Magenta Therapeutics price target lowered to $3 from $6 at BTIG
1y ago
Magenta Therapeutics Provides Update for MGTA-117 Phase 1/2 Dose Escalation Clinical Trial
PremiumPress Releases
Magenta Therapeutics Provides Update for MGTA-117 Phase 1/2 Dose Escalation Clinical Trial
1y ago
Magenta Therapeutics presents positive MGTA-117 clinical data at ASH
PremiumThe FlyMagenta Therapeutics presents positive MGTA-117 clinical data at ASH
1y ago
Credit Suisse to hold a conference
PremiumThe Fly
Credit Suisse to hold a conference
2y ago
Magenta Therapeutics to Present Data at the 2022 American Society of Hematology (ASH) Annual Meeting
PremiumPress Releases
Magenta Therapeutics to Present Data at the 2022 American Society of Hematology (ASH) Annual Meeting
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100